Brokerages remain mixed on Dr Lal PathLabs Q2 show; Citi maintains buy ratinghttps://www.moneycontrol.com/news/business/markets/brokerages-remain-mixed-on-dr-lal-pathlabs-q2-show-citi-maintains-buy-rating-3141861.html#LALPATHLAB